Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH: Glargine+OADs vs Premix Insulin in T2DM
NCT03359837Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2018
- Primary completion
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jan 2018; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03359837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359837.